Table 12_4_2.1
Hospital patients with an anticoagulant-related adverse drug event with warfarin, United States, 2004-2007 and 2009a
|
|
2009 |
2007 |
2006 |
2005 |
2004 |
Population group |
Sample size |
Percent |
SE |
Percent |
SE |
Percent |
SE |
Percent |
SE |
Percent |
SE |
Total |
|
2,759 |
4.39 |
0.39 |
4.23 |
0.33 |
6.21 |
0.38 |
6.89 |
0.41 |
8.76 |
0.47 |
Age |
Under 65 |
747 |
3.48 |
0.67 |
2.85 |
0.85 |
5.84 |
1.18 |
6.58 |
1.30 |
9.28 |
1.56 |
65-74 |
709 |
4.37 |
0.77 |
3.09 |
0.51 |
6.31 |
0.70 |
7.28 |
0.75 |
7.23 |
0.75 |
75-84 |
847 |
4.96 |
0.75 |
4.63 |
0.54 |
5.98 |
0.59 |
6.64 |
0.62 |
9.01 |
0.74 |
85 and over |
456 |
4.82 |
1.00 |
DNA |
DNA |
6.75 |
0.90 |
6.97 |
0.99 |
11.00 |
1.30 |
Gender |
Male |
1,272 |
3.85 |
0.54 |
4.01 |
0.48 |
6.26 |
0.57 |
6.77 |
0.61 |
8.57 |
0.71 |
Female |
1,487 |
4.84 |
0.56 |
4.41 |
0.45 |
6.17 |
0.51 |
6.98 |
0.55 |
8.91 |
0.63 |
Race |
White |
2,411 |
4.40 |
0.42 |
4.05 |
0.34 |
5.86 |
0.39 |
6.92 |
0.43 |
8.80 |
0.49 |
Black |
DSU |
DSU |
DSU |
5.22 |
1.47 |
8.96 |
1.74 |
6.64 |
1.56 |
7.86 |
1.78 |
Other |
DSU |
DSU |
DSU |
DSU |
DSU |
10.29 |
2.61 |
DSU |
DSU |
9.48 |
2.72 |
Diabetes |
Yes |
943 |
6.15 |
0.78 |
4.93 |
0.62 |
6.92 |
0.69 |
7.21 |
0.74 |
9.62 |
0.86 |
No |
1,816 |
3.47 |
0.43 |
3.89 |
0.39 |
5.86 |
0.45 |
6.74 |
0.49 |
8.35 |
0.56 |
Obesity |
Yes |
722 |
5.54 |
0.85 |
4.69 |
0.85 |
4.82 |
0.84 |
8.51 |
1.27 |
9.03 |
1.33 |
No |
2,037 |
3.98 |
0.43 |
4.14 |
0.36 |
6.48 |
0.42 |
6.66 |
0.43 |
8.72 |
0.50 |
Cerebrovascular disease |
Yes |
507 |
6.51 |
1.10 |
4.11 |
0.64 |
6.31 |
0.75 |
7.97 |
0.84 |
8.70 |
0.89 |
No |
2,252 |
3.91 |
0.41 |
4.28 |
0.39 |
6.18 |
0.44 |
6.49 |
0.46 |
8.79 |
0.55 |
CHF/pulmonary edema |
Yes |
1,280 |
5.08 |
0.61 |
4.87 |
0.54 |
6.97 |
0.61 |
7.55 |
0.66 |
10.05 |
0.77 |
No |
1,479 |
3.79 |
0.50 |
3.75 |
0.41 |
5.64 |
0.48 |
6.41 |
0.52 |
7.83 |
0.59 |
COPD |
Yes |
861 |
6.50 |
0.84 |
6.05 |
0.75 |
7.04 |
0.71 |
7.77 |
0.77 |
10.57 |
0.92 |
No |
1,898 |
3.42 |
0.42 |
3.54 |
0.36 |
5.82 |
0.45 |
6.48 |
0.48 |
7.96 |
0.54 |
Smoking |
Yes |
445 |
4.49 |
0.98 |
4.30 |
1.02 |
6.52 |
1.21 |
6.79 |
1.29 |
8.73 |
1.41 |
No |
2,314 |
4.36 |
0.42 |
4.22 |
0.35 |
6.18 |
0.40 |
6.90 |
0.43 |
8.77 |
0.50 |
Corticosteroids |
Yes |
182 |
10.44 |
2.27 |
4.19 |
1.14 |
8.44 |
1.55 |
10.86 |
1.66 |
14.19 |
2.05 |
No |
2,577 |
3.96 |
0.38 |
4.24 |
0.34 |
6.02 |
0.39 |
6.49 |
0.42 |
8.29 |
0.48 |
Coronary artery disease |
Yes |
1,255 |
5.18 |
0.63 |
4.79 |
0.50 |
6.82 |
0.58 |
6.75 |
0.58 |
10.62 |
0.73 |
No |
1,504 |
3.72 |
0.49 |
3.69 |
0.43 |
5.69 |
0.50 |
7.01 |
0.57 |
6.94 |
0.59 |
Renal disease |
Yes |
630 |
7.62 |
1.06 |
5.17 |
0.68 |
9.66 |
0.87 |
11.31 |
1.00 |
13.20 |
1.18 |
No |
2,129 |
3.43 |
0.39 |
3.87 |
0.37 |
4.81 |
0.40 |
5.32 |
0.42 |
7.47 |
0.50 |
a. Data were not collected in 2008. The 2004-2007 data include Medicare beneficiaries discharged from January to December and the 2009 data include Medicare beneficiaries discharged from January to September.
DNA - Data have not been analyzed.
DSU - Data do not meet the criteria for statistical reliability, data quality, or confidentiality.
Key: CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; SE: standard error.
Source: Centers for Medicare & Medicaid Services, Medicare Patient Safety Monitoring System.